We noted TAC was associated with a reduced risk of alopecia (RR: 0.25; 95%CI: 0.09–0.70; p = 0.008), infection (RR: 0.53; 95%CI: 0.29–0.99; p = 0.045), leukocytosis (RR: 0.19; 95%CI: 0.07–0.54; p = 0.002), and elevated ALT/AST (RR: 0.46; 95%CI: 0.25–0.84; p = 0.011) than CTX. Here, GPT is linked to alopecia.